Kinectin 1 inhibitors as a chemical class would comprise compounds that can indirectly affect the function of Kinectin 1 by modulating the cytoskeleton, ER-related processes, or cellular motor proteins. For example, drugs that destabilize microtubules, such as Nocodazole and Colchicine, could interfere with the role of Kinectin 1 in kinesin-dependent transport along microtubules. Conversely, Paclitaxel and Epothilone B, which stabilize microtubules, might also disrupt the dynamic interactions necessary for normal kinesin and Kinectin 1 function.
Additionally, compounds like Monastrol, an inhibitor of kinesin Eg5, could indirectly affect the motility functions related to Kinectin 1 by altering the mechanics of kinesin motors. ER stress inducers like Thapsigargin and Salubrinal might also influence Kinectin 1's function, as ER stress can lead to a global alteration in cellular transport and protein processing. Agents that impact protein glycosylation and trafficking, such as Tunicamycin and Kifunensine, could alter the post-translational modification of proteins that are transported by the KTN1-kinesin complex, thereby indirectly affecting its function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monastrol | 254753-54-3 | sc-202710 sc-202710A | 1 mg 5 mg | $120.00 $233.00 | 10 | |
Inhibitor of the kinesin Eg5, which may alter cellular transport processes involving KTN1. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
ER mannosidase I inhibitor that could affect glycoprotein processing, potentially impacting KTN1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation in the ER, which could indirectly influence KTN1 function. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER to Golgi transport, which may impact KTN1's role in vesicle trafficking. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor that can cause ER stress, potentially affecting Kinectin 1. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Selective inhibitor of eIF2α dephosphorylation, can induce ER stress, potentially influencing KTN1. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Disrupts intermediate filaments and could affect cellular transport processes involving KTN1. | ||||||